From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton ...
Anaheim, Calif. — Medical manufacturers are seeing overall growth in the market as it continues to rebound from high levels of inventory from the COVID-19 pandemic and responds to new drug development ...
Globus Medical saw fourth quarter net sales grow 6.6% year over year, and full year sales leapt 60.6%, according to financial results posted Feb. 20.
StockStory.org on MSN23h
Globus Medical’s (NYSE:GMED) Q4 Sales Beat EstimatesMedical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 ...
StockStory.org on MSN23h
Select Medical (NYSE:SEM) Misses Q4 Sales Targets, Stock DropsHealthcare services company Select Medical (NYSE:SEM) in Q4 CY2024, with sales falling 20.9% year on year to $1.31 billion. The company’s full-year revenue guidance of $5.5 billion at the midpoint ...
B, consensus $2.67B. “Our financial results demonstrate the potential of our combined organization and the growing value creation from the merger, ...
Costa Rica has approved comprehensive regulations for medical cannabis sales, enabling pharmacy access to cannabis products for patients ...
Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.
Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.
Haemonetics shares have been trading at more appealing levels after a reduction in full-year sales guidance. Check out my ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results